Saturday 17 October 2026 Export KRYS’s income statement to Excel — free account

Krystal Biotech, Inc.

Krystal Biotech, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $389.1 million, up 33.9% from fiscal 2024. In the quarter to June 2026, revenue grew 24.1%, EPS grew 39.1% and free cash flow grew 40.1%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

316.58 13.42 −4.07%

Follow KRYS

Alert me

Market cap: $9.8B
P/E: 38.3×
Fwd P/E: 38.6×
Dividend yield: —
F-score: 7/9
Altman Z: 39.03
Beneish M: −2.27
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	—	—	—	6
ROE Full definition →		19.66%	18.91%	19.90%	20.12%
ROA Full definition →		17.90%	17.14%	18.21%	18.30%
ROIC Full definition →		24.34%	25.73%	24.64%	24.07%
Return on Tangible Assets Full definition →		20.23%	19.10%	21.12%	22.23%
Average Days of Receivables Full definition →		126.80	119.52	111.10	114.90
Free Cash Flow per Share Full definition →		5.73	6.54	8.11	8.73
Free Cash Flow Full definition →		166.02	189.35	237.38	257.78
Capital Expenditures Full definition →		(10.18)	(11.52)	(12.89)	(14.56)
Other line items
Cash ROIC Full definition →		8.88%	9.25%	11.30%	11.69%
Accounts Receivable Turnover Full definition →		3.29	3.35	3.62	3.52
Accounts Payable Turnover Full definition →		5.58	5.61	7.20	3.46
Inventory Turnover Full definition →		0.76	0.69	0.67	0.62
Average Days of Payables Full definition →		35.76	51.28	61.31	101.14
Days of Inventory on Hand Full definition →		641.70	640.96	639.41	704.10
Tax Rate Full definition →		0.06	0.08	0.09	0.07
Research and Development Expense of Revenue Full definition →		15.22%	14.92%	14.17%	13.45%
Selling, General and Administrative Expense of Revenue Full definition →		36.60%	37.71%	37.17%	36.30%
Share Based Compensation of Revenue Full definition →		14.50%	14.01%	13.09%	12.41%
Operating CF/Net income Full definition →		0.89	0.98	1.11	1.13
Depreciation/Fixed assets Full definition →		0.04	0.04	0.04	0.04
Capex/Depreciation Full definition →		(1.60)	(1.76)	(1.94)	(2.18)
Revenue per Share Full definition →		12.89	13.44	14.25	14.92
Operating CF per Share Full definition →		6.09	6.94	8.55	9.22
Capex per Share Full definition →		(0.35)	(0.40)	(0.44)	(0.49)
Capex to Sales Full definition →		0.03	0.03	0.03	0.03

Show all line items

Columns are period end dates

Stockrow Weekly